Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells

Oncology Research

Volumn 21, Issue 2, 2014, Pages 93-102

  Warner, Sudha ^a   Balu, Senthil Kumar ^a   Kumar, Alan Prem ^b,c,d,e   Millward, Michael ^f   Dharmarajan, Arunasalam ^e,f  

^a Manipal Academy of Higher Education   (India)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF NORTH TEXAS   (United States)

^e CURTIN UNIVERSITY   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptosis; Chemosensitivity; Glioma stem cells (GSCs); Secreted frizzled related protein 4 (sFRP4); Wnt antagonist

Indexed keywords

BETA CATENIN; CASPASE 3; CD133 ANTIGEN; CISPLATIN; CYCLIN D1; DOXORUBICIN; PROTEIN BAX; PROTEIN P21; SECRETED FRIZZLED RELATED PROTEIN 4; WNT3A PROTEIN; ANTINEOPLASTIC AGENT; ONCOPROTEIN; SFRP4 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DOWN REGULATION; ENZYME ACTIVITY; GLIOMA CELL LINE; GLIOMA STEM CELL; IC50; METASTASIS; MOLECULARLY TARGETED THERAPY; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TREATMENT RESPONSE; UPREGULATION; WNT SIGNALING PATHWAY; BRAIN TUMOR; CANCER STEM CELL; CELL CYCLE CHECKPOINT; DRUG EFFECT; DRUG POTENTIATION; GLIOBLASTOMA; HUMAN; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BRAIN NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG SYNERGISM; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS; SPHEROIDS, CELLULAR; WNT3A PROTEIN;

EID: 84904738963     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13786659070154     Document Type: Article

References (21)

1. Zhuand, J.; Parada, L. F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer 2:616-626; 2002.
2. Islam, M. O.; Kanemura, Y.; Tajria, J.; Mori, H.; Kobayashi, S.; Shofuda, T.; Miyake, J.; Hara, M.; Yamasaki, M.; Okano, H. Characterization of ABC transporter ABCB1 expressed in human neural stem/progenitor cells. FEBS Lett. 579:3473-3480;2005.
3. Kawano, Y.; Kypta, R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116:2627-2634;2003.
4. Saran, U.; Arfuso, F.; Zeps, N.; Dharmarajan, A. Secreted frizzled-related protein 4 levels reflect the responsiveness of ovarian cancer cell lines in vitro and are associated with tumour grade in vivo. BMC Cell Biol. 2121:13-25; 2012.
5. Warrier, S.; Pavanram, P.; Raina, D.; Arvind, M. Study of chemoresistant CD 133+ Cancer Stem Cells from human glioblastoma cell line U138MG using multiple assays. Cell Biol. Int. 36:1137-1143;2012.
6. Beltran, E.; Fresquet, V.; Martinez-Useros, J.; Richter-Larrea J. A.; Sagardoy, A.; Sesma, I.; Almada, L. L.; Montes-Moreno, S.; Siebert, R.; Gesk, S; Calasanz, M. J.; Malumbres, R.; Rieger, M; Prosper, R; Lossos, I. S.; Piris, M. A.; Fernandez-Zapico, M. E.; Martinez-Climent, J. A. A cyclin-Dl interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 26:12461-12466;2011.
7. Lobo, N. A.; Shimono, Y.; Qian, D.; Clarke, M. F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23:675-699; 2007.
8. Bleau. A. M.; Hambardzumyan, D.; Ozawa, T.; Fomchenko, E. I.; Huse J. T.; Brennan, C. W.; Holland, E. C. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4:226-235; 2009.
9. Linhart, H. G.; Lin, H.; Yamada, Y.; Moran, E.; Steine, E. J.; Gokhale, S.; Lo, G.; Cantu, E.; Ehrich, M.; He, T.; Meissner, A.; Jaenisch, R. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev. 21:3110-3122;2007.
10. Hsieh, M.; Mulders, S. M.; Friis, R. R.; Dharmarajan, A.; Richards, J. S. Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: Evidence for selective up-regulation in luteinized granulosa cells. Endocrinology 144:4597-4606;2003.
11. Lacher, M. D.; Siegenthaler, A.; Jager, R.; Yan, X.; Hett, S.; Xuan, L.; Saurer, S.; Lareu, R. R.; Dharmarajan, A. M.; Friis, R. Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Diff. 10:528-538; 2003.
12. Constantinou, T.; Baumann, F; Lacher, M. D.; Saurer, S.; Friis, R.; Dharmarajan, A. SFRP-4 abrogates Wnt-3ainduced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation. J. Mol. Signal. 2:3-10; 2008.
13. He, B.; Lee, A. Y; Dadfarmay, S.; You, L.; Xu, Z.; Reguart, N.; Mazieres, J.; Mikami, I.; McCormick, F; Jablons, D. M. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenindeficient human mesothelioma cells. Cancer Res. 65:743-748; 2005.
14. Lee, A. Y; He, B.; You, L.; Dadfarmay, S.; Xu, Z.; Mazieres, J.; Mikami, I.; McCormick F; Jablons, D. M. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23:6672-6676;2004.
15. Gosepath, E. M.; Eckstein, N.; Hamacher, A.; Servan, K.; Von Jonquieres, G.; Lage, H.; Györffy, B.; Royer, H. D.; Kassack, M. U. Acquired cisplatin resistance in the headneck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1. Int. J. Cancer 123:2013-2019;2008.
16. Agarwal, R.; Kaye, S. B. Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 3:502-516; 2003.
17. Balch, C; Huang, T. H.; Brown, R; Nephew, K. P. The epigenetics of ovarian cancer drug resistance and resensitization. Am. J. Obstet. Gynecol. 191:1552-1572;2004.
18. Liu, X.; Kim, C. N.; Yang, J.; Jemmerson, R.; Wang, X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157; 1996.
19. Ando, T; Kawabe, T; Ohara, H.; Ducommun, B.; Itoh, M.; Okamoto, T. Involvement of the interaction between p21 and PCNA for the maintenance of G2/M arrest after DNA damage. J. Biol. Chem. 16; 276:42971-42977;2001.
20. Zhang, N.; Wei, P.; Gong, A.; Chiu, W. T; Lee, H. T; Colman, H.; Huang, H.; Xue, J.; Liu, M.; Wang, Y; Sawaya, R.; Xie, K.; Yung, W K.; Medema, R. H.; He, X.; Huang, S. FoxM 1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis, Cancer Cell 20:427-442; 2011.
21. Campos, B.; Wan, F; Farhadi, M.; Ernst, A.; Zeppernick F; Tagscherer K. E.; Ahmadi, R.; Lohr, J.; Dictus, C; Gdynia, G.; Combs, S. E.; Goidts, V.; Helmke, B. M.; Eckstein, V.; Roth, W.; Beckhove, P.; Lichter, P.; Unterberg, A.; Radlwimmer, B.; Herold-Mende, C. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin. Cancer Res. 16:2715-2728;2010.